Lantern Pharma Inc. (LTRN) Financials
LTRN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 47.8 million | 2.4 million |
| 2023-06-30 | 51.4 million | 3.2 million |
| 2023-03-31 | 55.5 million | 2.9 million |
| 2022-12-31 | 58.8 million | 2.8 million |
LTRN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -3.6 million | 190755 |
| 2023-06-30 | -3.6 million | 392390 |
| 2023-03-31 | -3.8 million | 333530 |
| 2022-12-31 | -2.7 million | 330095 |
LTRN Net Income
No data available :(
LTRN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 44.9 million | - | 274529 |
| 2023-06-30 | 47.9 million | - | 313859 |
| 2023-03-31 | 51.5 million | - | 260216 |
| 2022-12-31 | 55.2 million | - | 52890 |
LTRN Shares Outstanding
LTRN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 4777 | 2.2 million | 1.3 million | - |
| 2023-06-30 | - | 3.6 million | 1.6 million | - |
| 2023-03-31 | 8876 | 2.6 million | 1.7 million | - |
| 2022-12-31 | 6955 | 2.3 million | 1.6 million | - |
LTRN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 43325 |
| 2023-06-30 | - | 43758 |
| 2023-03-31 | - | 43443 |
| 2022-12-31 | - | 38909 |
LTRN
Price: $6.26
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -3.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2116
Market Capitalization: 74.3 million